Global Therapeutic Nuclear Medicines Market 2018 - Research Report, Demand, Price, By Application, Region and Forecast to 2025

 Published Date : Aug-2018   |    Format :PDF |    Number of Pages : 101   |    Publisher : e-Market Research

This report studies the global Therapeutic Nuclear Medicines market status and forecast, categorizes the global Therapeutic Nuclear Medicines market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

In 2017, the global Therapeutic Nuclear Medicines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.

The major players covered in this report
    Cardinal Health
    Mallinckrodt
    GE Healthcare
    Lantheus Medical Imaging
    Bayer
    Bracco Imaging
    Eczacibasi-Monrol Nuclear Products
    Nordion
    Advanced Accelerator Applications
    IBA Molecular Imaging

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
    United States
    Europe
    China
    Japan
    Southeast Asia
    India

The regional scope of the study is as follows:
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
    Central & South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Beta Emitters
    Alpha Emitters
    Brachytherapy Products
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Thyroid
    Bone Metastasis
    Lymphoma
    Endocrine Tumors
    Others

The study objectives of this report are:
    To analyze and study the global Therapeutic Nuclear Medicines sales, value, status (2013-2017) and forecast (2018-2025);
    To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
    Focuses on the key Therapeutic Nuclear Medicines players, to study the sales, value, market share and development plans in future.
    Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Therapeutic Nuclear Medicines are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Therapeutic Nuclear Medicines Manufacturers
Therapeutic Nuclear Medicines Distributors/Traders/Wholesalers
Therapeutic Nuclear Medicines Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Therapeutic Nuclear Medicines market, by end-use.
Detailed analysis and profiles of additional market players.

Global Therapeutic Nuclear Medicines Sales Market Report 2018
1 Therapeutic Nuclear Medicines Market Overview
    1.1 Product Overview and Scope of Therapeutic Nuclear Medicines
    1.2 Classification of Therapeutic Nuclear Medicines by Product Category
        1.2.1 Global Therapeutic Nuclear Medicines Market Size (Sales) Comparison by Type (2013-2025)
        1.2.2 Global Therapeutic Nuclear Medicines Market Size (Sales) Market Share by Type (Product Category) in 2017
        1.2.3 Beta Emitters
        1.2.4 Alpha Emitters
        1.2.5 Brachytherapy Products
    1.3 Global Therapeutic Nuclear Medicines Market by Application/End Users
        1.3.1 Global Therapeutic Nuclear Medicines Sales (Volume) and Market Share Comparison by Application (2013-2025)
        1.3.2 Thyroid
        1.3.3 Bone Metastasis
        1.3.4 Lymphoma
        1.3.5 Endocrine Tumors
        1.3.6 Others
    1.4 Global Therapeutic Nuclear Medicines Market by Region
        1.4.1 Global Therapeutic Nuclear Medicines Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 United States Therapeutic Nuclear Medicines Status and Prospect (2013-2025)
        1.4.3 Europe Therapeutic Nuclear Medicines Status and Prospect (2013-2025)
        1.4.4 China Therapeutic Nuclear Medicines Status and Prospect (2013-2025)
        1.4.5 Japan Therapeutic Nuclear Medicines Status and Prospect (2013-2025)
        1.4.6 Southeast Asia Therapeutic Nuclear Medicines Status and Prospect (2013-2025)
        1.4.7 India Therapeutic Nuclear Medicines Status and Prospect (2013-2025)
    1.5 Global Market Size (Value and Volume) of Therapeutic Nuclear Medicines (2013-2025)
        1.5.1 Global Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2025)
        1.5.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate (2013-2025)

2 Global Therapeutic Nuclear Medicines Competition by Players/Suppliers, Type and Application
     2.1 Global Therapeutic Nuclear Medicines Market Competition by Players/Suppliers
        2.1.1 Global Therapeutic Nuclear Medicines Sales and Market Share of Key Players/Suppliers (2013-2018)
        2.1.2 Global Therapeutic Nuclear Medicines Revenue and Share by Players/Suppliers (2013-2018)
    2.2 Global Therapeutic Nuclear Medicines (Volume and Value) by Type
        2.2.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Type (2013-2018)
        2.2.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2013-2018)
    2.3 Global Therapeutic Nuclear Medicines (Volume and Value) by Region
        2.3.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Region (2013-2018)
        2.3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Region (2013-2018)
    2.4 Global Therapeutic Nuclear Medicines (Volume) by Application

3 United States Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
    3.1 United States Therapeutic Nuclear Medicines Sales and Value (2013-2018)
        3.1.1 United States Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
        3.1.2 United States Therapeutic Nuclear Medicines Revenue and Growth Rate (2013-2018)
        3.1.3 United States Therapeutic Nuclear Medicines Sales Price Trend (2013-2018)
    3.2 United States Therapeutic Nuclear Medicines Sales Volume and Market Share by Players (2013-2018)
    3.3 United States Therapeutic Nuclear Medicines Sales Volume and Market Share by Type (2013-2018)
    3.4 United States Therapeutic Nuclear Medicines Sales Volume and Market Share by Application (2013-2018)

4 Europe Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
    4.1 Europe Therapeutic Nuclear Medicines Sales and Value (2013-2018)
        4.1.1 Europe Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
        4.1.2 Europe Therapeutic Nuclear Medicines Revenue and Growth Rate (2013-2018)
        4.1.3 Europe Therapeutic Nuclear Medicines Sales Price Trend (2013-2018)
    4.2 Europe Therapeutic Nuclear Medicines Sales Volume and Market Share by Players (2013-2018)
    4.3 Europe Therapeutic Nuclear Medicines Sales Volume and Market Share by Type (2013-2018)
    4.4 Europe Therapeutic Nuclear Medicines Sales Volume and Market Share by Application (2013-2018)

5 China Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
    5.1 China Therapeutic Nuclear Medicines Sales and Value (2013-2018)
        5.1.1 China Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
        5.1.2 China Therapeutic Nuclear Medicines Revenue and Growth Rate (2013-2018)
        5.1.3 China Therapeutic Nuclear Medicines Sales Price Trend (2013-2018)
    5.2 China Therapeutic Nuclear Medicines Sales Volume and Market Share by Players (2013-2018)
    5.3 China Therapeutic Nuclear Medicines Sales Volume and Market Share by Type (2013-2018)
    5.4 China Therapeutic Nuclear Medicines Sales Volume and Market Share by Application (2013-2018)

6 Japan Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
    6.1 Japan Therapeutic Nuclear Medicines Sales and Value (2013-2018)
        6.1.1 Japan Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
        6.1.2 Japan Therapeutic Nuclear Medicines Revenue and Growth Rate (2013-2018)
        6.1.3 Japan Therapeutic Nuclear Medicines Sales Price Trend (2013-2018)
    6.2 Japan Therapeutic Nuclear Medicines Sales Volume and Market Share by Players (2013-2018)
    6.3 Japan Therapeutic Nuclear Medicines Sales Volume and Market Share by Type (2013-2018)
    6.4 Japan Therapeutic Nuclear Medicines Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
    7.1 Southeast Asia Therapeutic Nuclear Medicines Sales and Value (2013-2018)
        7.1.1 Southeast Asia Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
        7.1.2 Southeast Asia Therapeutic Nuclear Medicines Revenue and Growth Rate (2013-2018)
        7.1.3 Southeast Asia Therapeutic Nuclear Medicines Sales Price Trend (2013-2018)
    7.2 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Market Share by Players (2013-2018)
    7.3 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Market Share by Type (2013-2018)
    7.4 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Market Share by Application (2013-2018)

8 India Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
    8.1 India Therapeutic Nuclear Medicines Sales and Value (2013-2018)
        8.1.1 India Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
        8.1.2 India Therapeutic Nuclear Medicines Revenue and Growth Rate (2013-2018)
        8.1.3 India Therapeutic Nuclear Medicines Sales Price Trend (2013-2018)
    8.2 India Therapeutic Nuclear Medicines Sales Volume and Market Share by Players (2013-2018)
    8.3 India Therapeutic Nuclear Medicines Sales Volume and Market Share by Type (2013-2018)
    8.4 India Therapeutic Nuclear Medicines Sales Volume and Market Share by Application (2013-2018)

9 Global Therapeutic Nuclear Medicines Players/Suppliers Profiles and Sales Data
    9.1 Cardinal Health
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Cardinal Health Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
        9.1.4 Main Business/Business Overview
    9.2 Mallinckrodt
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Mallinckrodt Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
        9.2.4 Main Business/Business Overview
    9.3 GE Healthcare
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 GE Healthcare Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
        9.3.4 Main Business/Business Overview
    9.4 Lantheus Medical Imaging
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
        9.4.4 Main Business/Business Overview
    9.5 Bayer
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
        9.5.4 Main Business/Business Overview
    9.6 Bracco Imaging
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Bracco Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
        9.6.4 Main Business/Business Overview
    9.7 Eczacibasi-Monrol Nuclear Products
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
        9.7.4 Main Business/Business Overview
    9.8 Nordion
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Nordion Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
        9.8.4 Main Business/Business Overview
    9.9 Advanced Accelerator Applications
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Advanced Accelerator Applications Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
        9.9.4 Main Business/Business Overview
    9.10 IBA Molecular Imaging
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 IBA Molecular Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
        9.10.4 Main Business/Business Overview

10 Therapeutic Nuclear Medicines Maufacturing Cost Analysis
    10.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines
    10.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Therapeutic Nuclear Medicines Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2017
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Therapeutic Nuclear Medicines Market Forecast (2018-2025)
    14.1 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Price Forecast (2018-2025)
       14.1.1 Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate Forecast (2018-2025)
       14.1.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2018-2025)
       14.1.3 Global Therapeutic Nuclear Medicines Price and Trend Forecast (2018-2025)
    14.2 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
       14.2.1 Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate Forecast by Regions (2018-2025)
       14.2.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast by Regions (2018-2025)
       14.2.3 United States Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.4 Europe Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.5 China Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.6 Japan Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.7 Southeast Asia Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.8 India Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    14.3 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Price Forecast by Type (2018-2025)
       14.3.1 Global Therapeutic Nuclear Medicines Sales Forecast by Type (2018-2025)
       14.3.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2018-2025)
       14.3.3 Global Therapeutic Nuclear Medicines Price Forecast by Type (2018-2025)
    14.4 Global Therapeutic Nuclear Medicines Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer



List of Tables and Figures

    Figure Product Picture of Therapeutic Nuclear Medicines
    Figure Global Therapeutic Nuclear Medicines Sales Volume Comparison (K Units) by Type (2013-2025)
    Figure Global Therapeutic Nuclear Medicines Sales Volume Market Share by Type (Product Category) in 2017
    Figure Beta Emitters Product Picture
    Figure Alpha Emitters Product Picture
    Figure Brachytherapy Products Product Picture
    Figure Global Therapeutic Nuclear Medicines Sales Comparison (K Units) by Application (2013-2025)
    Figure Global Sales Market Share of Therapeutic Nuclear Medicines by Application in 2017
    Figure Thyroid Examples
    Table Key Downstream Customer in Thyroid
    Figure Bone Metastasis Examples
    Table Key Downstream Customer in Bone Metastasis
    Figure Lymphoma Examples
    Table Key Downstream Customer in Lymphoma
    Figure Endocrine Tumors Examples
    Table Key Downstream Customer in Endocrine Tumors
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure Global Therapeutic Nuclear Medicines Market Size (Million USD) by Regions (2013-2025)
    Figure United States Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Europe Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
    Figure China Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Japan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southeast Asia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
    Figure India Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Global Therapeutic Nuclear Medicines Sales Volume (K Units) and Growth Rate (2013-2025)
    Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Global Market Major Players Therapeutic Nuclear Medicines Sales Volume (K Units) (2013-2018)
    Table Global Therapeutic Nuclear Medicines Sales (K Units) of Key Players/Suppliers (2013-2018)
    Table Global Therapeutic Nuclear Medicines Sales Share by Players/Suppliers (2013-2018)
    Figure 2017 Therapeutic Nuclear Medicines Sales Share by Players/Suppliers
    Figure 2017 Therapeutic Nuclear Medicines Sales Share by Players/Suppliers
    Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table Global Therapeutic Nuclear Medicines Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table Global Therapeutic Nuclear Medicines Revenue Share by Players/Suppliers (2013-2018)
    Table 2017 Global Therapeutic Nuclear Medicines Revenue Share by Players
    Table 2017 Global Therapeutic Nuclear Medicines Revenue Share by Players
    Table Global Therapeutic Nuclear Medicines Sales (K Units) and Market Share by Type (2013-2018)
    Table Global Therapeutic Nuclear Medicines Sales Share (K Units) by Type (2013-2018)
    Figure Sales Market Share of Therapeutic Nuclear Medicines by Type (2013-2018)
    Figure Global Therapeutic Nuclear Medicines Sales Growth Rate by Type (2013-2018)
    Table Global Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Type (2013-2018)
    Table Global Therapeutic Nuclear Medicines Revenue Share by Type (2013-2018)
    Figure Revenue Market Share of Therapeutic Nuclear Medicines by Type (2013-2018)
    Figure Global Therapeutic Nuclear Medicines Revenue Growth Rate by Type (2013-2018)
    Table Global Therapeutic Nuclear Medicines Sales Volume (K Units) and Market Share by Region (2013-2018)
    Table Global Therapeutic Nuclear Medicines Sales Share by Region (2013-2018)
    Figure Sales Market Share of Therapeutic Nuclear Medicines by Region (2013-2018)
    Figure Global Therapeutic Nuclear Medicines Sales Growth Rate by Region in 2017
    Table Global Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Region (2013-2018)
    Table Global Therapeutic Nuclear Medicines Revenue Share (%) by Region (2013-2018)
    Figure Revenue Market Share of Therapeutic Nuclear Medicines by Region (2013-2018)
    Figure Global Therapeutic Nuclear Medicines Revenue Growth Rate by Region in 2017
    Table Global Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Region (2013-2018)
    Table Global Therapeutic Nuclear Medicines Revenue Share (%) by Region (2013-2018)
    Figure Revenue Market Share of Therapeutic Nuclear Medicines by Region (2013-2018)
    Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Region in 2017
    Table Global Therapeutic Nuclear Medicines Sales Volume (K Units) and Market Share by Application (2013-2018)
    Table Global Therapeutic Nuclear Medicines Sales Share (%) by Application (2013-2018)
    Figure Sales Market Share of Therapeutic Nuclear Medicines by Application (2013-2018)
    Figure Global Therapeutic Nuclear Medicines Sales Market Share by Application (2013-2018)
    Figure United States Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
    Figure United States Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2018)
    Figure United States Therapeutic Nuclear Medicines Sales Price (USD/Unit) Trend (2013-2018)
    Table United States Therapeutic Nuclear Medicines Sales Volume (K Units) by Players (2013-2018)
    Table United States Therapeutic Nuclear Medicines Sales Volume Market Share by Players (2013-2018)
    Figure United States Therapeutic Nuclear Medicines Sales Volume Market Share by Players in 2017
    Table United States Therapeutic Nuclear Medicines Sales Volume (K Units) by Type (2013-2018)
    Table United States Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2013-2018)
    Figure United States Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2017
    Table United States Therapeutic Nuclear Medicines Sales Volume (K Units) by Application (2013-2018)
    Table United States Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2013-2018)
    Figure United States Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2017
    Figure Europe Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
    Figure Europe Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Europe Therapeutic Nuclear Medicines Sales Price (USD/Unit) Trend (2013-2018)
    Table Europe Therapeutic Nuclear Medicines Sales Volume (K Units) by Players (2013-2018)
    Table Europe Therapeutic Nuclear Medicines Sales Volume Market Share by Players (2013-2018)
    Figure Europe Therapeutic Nuclear Medicines Sales Volume Market Share by Players in 2017
    Table Europe Therapeutic Nuclear Medicines Sales Volume (K Units) by Type (2013-2018)
    Table Europe Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2013-2018)
    Figure Europe Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2017
    Table Europe Therapeutic Nuclear Medicines Sales Volume (K Units) by Application (2013-2018)
    Table Europe Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2013-2018)
    Figure Europe Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2017
    Figure China Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
    Figure China Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2018)
    Figure China Therapeutic Nuclear Medicines Sales Price (USD/Unit) Trend (2013-2018)
    Table China Therapeutic Nuclear Medicines Sales Volume (K Units) by Players (2013-2018)
    Table China Therapeutic Nuclear Medicines Sales Volume Market Share by Players (2013-2018)
    Figure China Therapeutic Nuclear Medicines Sales Volume Market Share by Players in 2017
    Table China Therapeutic Nuclear Medicines Sales Volume (K Units) by Type (2013-2018)
    Table China Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2013-2018)
    Figure China Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2017
    Table China Therapeutic Nuclear Medicines Sales Volume (K Units) by Application (2013-2018)
    Table China Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2013-2018)
    Figure China Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2017
    Figure Japan Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
    Figure Japan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Japan Therapeutic Nuclear Medicines Sales Price (USD/Unit) Trend (2013-2018)
    Table Japan Therapeutic Nuclear Medicines Sales Volume (K Units) by Players (2013-2018)
    Table Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Players (2013-2018)
    Figure Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Players in 2017
    Table Japan Therapeutic Nuclear Medicines Sales Volume (K Units) by Type (2013-2018)
    Table Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2013-2018)
    Figure Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2017
    Table Japan Therapeutic Nuclear Medicines Sales Volume (K Units) by Application (2013-2018)
    Table Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2013-2018)
    Figure Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2017
    Figure Southeast Asia Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
    Figure Southeast Asia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Southeast Asia Therapeutic Nuclear Medicines Sales Price (USD/Unit) Trend (2013-2018)
    Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume (K Units) by Players (2013-2018)
    Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Players (2013-2018)
    Figure Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Players in 2017
    Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume (K Units) by Type (2013-2018)
    Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2013-2018)
    Figure Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2017
    Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume (K Units) by Application (2013-2018)
    Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2013-2018)
    Figure Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2017
    Figure India Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
    Figure India Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2018)
    Figure India Therapeutic Nuclear Medicines Sales Price (USD/Unit) Trend (2013-2018)
    Table India Therapeutic Nuclear Medicines Sales Volume (K Units) by Players (2013-2018)
    Table India Therapeutic Nuclear Medicines Sales Volume Market Share by Players (2013-2018)
    Figure India Therapeutic Nuclear Medicines Sales Volume Market Share by Players in 2017
    Table India Therapeutic Nuclear Medicines Sales Volume (K Units) by Type (2013-2018)
    Table India Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2013-2018)
    Figure India Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2017
    Table India Therapeutic Nuclear Medicines Sales Volume (K Units) by Application (2013-2018)
    Table India Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2013-2018)
    Figure India Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2017
    Table Cardinal Health Basic Information List
    Table Cardinal Health Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Cardinal Health Therapeutic Nuclear Medicines Sales Growth Rate (2013-2018)
    Figure Cardinal Health Therapeutic Nuclear Medicines Sales Global Market Share (2013-2018)
    Figure Cardinal Health Therapeutic Nuclear Medicines Revenue Global Market Share (2013-2018)
    Table Mallinckrodt Basic Information List
    Table Mallinckrodt Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Mallinckrodt Therapeutic Nuclear Medicines Sales Growth Rate (2013-2018)
    Figure Mallinckrodt Therapeutic Nuclear Medicines Sales Global Market Share (2013-2018)
    Figure Mallinckrodt Therapeutic Nuclear Medicines Revenue Global Market Share (2013-2018)
    Table GE Healthcare Basic Information List
    Table GE Healthcare Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure GE Healthcare Therapeutic Nuclear Medicines Sales Growth Rate (2013-2018)
    Figure GE Healthcare Therapeutic Nuclear Medicines Sales Global Market Share (2013-2018
    Figure GE Healthcare Therapeutic Nuclear Medicines Revenue Global Market Share (2013-2018)
    Table Lantheus Medical Imaging Basic Information List
    Table Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales Growth Rate (2013-2018)
    Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales Global Market Share (2013-2018)
    Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Revenue Global Market Share (2013-2018)
    Table Bayer Basic Information List
    Table Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Bayer Therapeutic Nuclear Medicines Sales Growth Rate (2013-2018)
    Figure Bayer Therapeutic Nuclear Medicines Sales Global Market Share (2013-2018)
    Figure Bayer Therapeutic Nuclear Medicines Revenue Global Market Share (2013-2018)
    Table Bracco Imaging Basic Information List
    Table Bracco Imaging Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Bracco Imaging Therapeutic Nuclear Medicines Sales Growth Rate (2013-2018)
    Figure Bracco Imaging Therapeutic Nuclear Medicines Sales Global Market Share (2013-2018
    Figure Bracco Imaging Therapeutic Nuclear Medicines Revenue Global Market Share (2013-2018)
    Table Eczacibasi-Monrol Nuclear Products Basic Information List
    Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales Growth Rate (2013-2018)
    Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales Global Market Share (2013-2018)
    Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Revenue Global Market Share (2013-2018)
    Table Nordion Basic Information List
    Table Nordion Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Nordion Therapeutic Nuclear Medicines Sales Growth Rate (2013-2018)
    Figure Nordion Therapeutic Nuclear Medicines Sales Global Market Share (2013-2018
    Figure Nordion Therapeutic Nuclear Medicines Revenue Global Market Share (2013-2018)
    Table Advanced Accelerator Applications Basic Information List
    Table Advanced Accelerator Applications Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Advanced Accelerator Applications Therapeutic Nuclear Medicines Sales Growth Rate (2013-2018)
    Figure Advanced Accelerator Applications Therapeutic Nuclear Medicines Sales Global Market Share (2013-2018)
    Figure Advanced Accelerator Applications Therapeutic Nuclear Medicines Revenue Global Market Share (2013-2018)
    Table IBA Molecular Imaging Basic Information List
    Table IBA Molecular Imaging Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales Growth Rate (2013-2018)
    Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales Global Market Share (2013-2018)
    Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Revenue Global Market Share (2013-2018)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Therapeutic Nuclear Medicines
    Figure Manufacturing Process Analysis of Therapeutic Nuclear Medicines
    Figure Therapeutic Nuclear Medicines Industrial Chain Analysis
    Table Raw Materials Sources of Therapeutic Nuclear Medicines Major Players in 2017
    Table Major Buyers of Therapeutic Nuclear Medicines
    Table Distributors/Traders List
    Figure Global Therapeutic Nuclear Medicines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Global Therapeutic Nuclear Medicines Price (USD/Unit) and Trend Forecast (2018-2025)
    Table Global Therapeutic Nuclear Medicines Sales Volume (K Units) Forecast by Regions (2018-2025)
    Figure Global Therapeutic Nuclear Medicines Sales Volume Market Share Forecast by Regions (2018-2025)
    Figure Global Therapeutic Nuclear Medicines Sales Volume Market Share Forecast by Regions in 2025
    Table Global Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Regions (2018-2025)
    Figure Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Regions (2018-2025)
    Figure Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Regions in 2025
    Figure United States Therapeutic Nuclear Medicines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure United States Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Europe Therapeutic Nuclear Medicines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Europe Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2018-2025)
    Figure China Therapeutic Nuclear Medicines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure China Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Japan Therapeutic Nuclear Medicines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Japan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Therapeutic Nuclear Medicines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure India Therapeutic Nuclear Medicines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure India Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Global Therapeutic Nuclear Medicines Sales (K Units) Forecast by Type (2018-2025)
    Figure Global Therapeutic Nuclear Medicines Sales Volume Market Share Forecast by Type (2018-2025)
    Table Global Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Type (2018-2025)
    Figure Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Type (2018-2025)
    Table Global Therapeutic Nuclear Medicines Price (USD/Unit) Forecast by Type (2018-2025)
    Table Global Therapeutic Nuclear Medicines Sales (K Units) Forecast by Application (2018-2025)
    Figure Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Application (2018-2025)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

 Select a Format



 Buy Now

24/7 Customer Support

Have questions?

Direct
+1-386-310-3803
Toll Free
+1-855-465-4651
sales@e-marketresearch.com